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Abstract
Antibiotic resistance markers, typically kanamycin resistance (kanR), allow selective 
retention of plasmid DNA during bacterial fermentation and are the most commonly 
utilized selectable markers.  However, to ensure safety, regulatory agencies recommend 
elimination of antibiotic resistance markers from therapeutic and vaccine plasmid DNA 
vectors.  The presence of an antibiotic resistance gene in the plasmid backbone is 
considered undesirable by regulatory agencies, due to: 1) the potential transfer of 
antibiotic resistance to endogenous microbial flora; and 2) the potential activation and 
transcription of the genes from mammalian promoters after cellular incorporation into 
the genome. Here, we describe the development and application of a novel antibiotic-
free (AF) selection system (Fig. 1). Vectors with this selection system (Fig. 4) 
incorporate and express a 150 bp RNA-OUT antisense RNA. RNA-OUT represses 
expression of a counter-selectable marker (SacB) from the host chromosome.  SacB 
encodes a levansucrase, which is toxic in the presence of sucrose.  Sucrose selectable 
DNA vaccine vectors combine antibiotic-free selection with highly productive 
fermentation manufacturing (>1 g/L plasmid DNA yields; Table 1, 3), while improving in 
vivo expression of encoded proteins (Fig. 3). The RNA-OUT selectable marker can be 
used to retrofit existing kanR DNA vaccine plasmids into antibiotic-free vectors. 
Interestingly, a minimum vector size for high yield production of small plasmids is 




E. coli DH5α: F- Φ 80dlacZΔM15  Δ(lacZYA -argF) U169 recA1 endA1 hsdR17(rK-, 
mK+) phoA supE44 λ- thi-1 gyrA96 relA1; NTC4862 DH5α attλ::P5/6 6/6-RNA-IN- SacB, 
catR
Plasmids NTC8385, NTC8485 and NTC8685 contains a 150 bp DraIII-KpnI RNA-OUT 
based sucrose selectable marker. NTC8485 and NTC8685 contain the high yield SV40-
PASBH backbone also present in the kanR vector  NTC7485  (Williams et al., 2009).
NTC fermentation media (Carnes et al., 2006) was modified to contain 0.5% sucrose 
for plasmid selection.  Fermentation was as described in Carnes et al., 2009.
Conclusions
We report the development of antibiotic-free (AF) DNA Vaccine vectors that combine >1 
gm/L fermentation yields of high quality plasmid with improved in vivo expression and 
immunogenicity. The RNA based selectable marker has general utility for retrofitting 
antibiotic-containing vectors such as gWiz. The AF expression vector backbones are 
optimized to exceed a newly identified size threshold for high copy plasmid replication.
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Results
Production/expression
Antibiotic-free  (AF) selection vectors direct higher transgene expression than 
alternative vectors such as gWIZ or pVAX vectors (Fig. 3) and are compatible for high 
yield production (>1 g/L; Tables 1 & 3) with a low metabolic burden inducible (30-42ºC) 
fed-batch fermentation process (Carnes et al., 2006; Williams et al., 2009) (Fig. 2). 
gWIZ vector retrofit to AF selection
The gWiz vector (VR1012 equivalent), a commonly utilized kanR DNA vaccine vector, 
was retrofitted with the RNA-OUT selectable marker (both potential orientations) by 
precise replacement of the kanR gene (ATG-TAA) and fermentation yield and 
eukaryotic expression determined. RNA-OUT orientation 2 (Fig. 4; AF2) has equivalent 
fermentation copy number and eukaryotic expression as the parent vector (Table 1). 
AF vector in vivo expression and immunogenicity
AF and KanR influenza H5 hemagglutinin (HA) DNA vaccine plasmids were tested for 
immunogenicity. Expression levels for each vector were determined,  using SEAP 
expressing versions of the vectors. Either 3 μg HA or SEAP plasmid was injected intra-
muscular (IM, quadriceps) of female BALB/c mice (6-8 weeks old) in a single dose (day 
0) prior to electroporation (EP) using the MedPulser® system (Inovio Biomedical, San 
Diego CA). Serum samples were taken and tested for SEAP or anti-HA IgG response. 
The results are summarized in Table 2 and demonstrate the antibiotic free NTC 
backbone (Fig. 4) is equivalent or superior to the kanR backbone for expression and 
immunogenicity (Luke et al., 2009).
Table 2: KanR and AF vector in vivo expression  (SEAP) and immunogenicity (HA)*.
* Results presented as average ± standard deviation.















Fig. 1: Antibiotic Free 
(AF) selection



















3.59 Sucrose 775 2.5
NTC8485-
KGF
3.80 Sucrose 1210 4.4
NTC8685-
KGF
3.68 Sucrose 1055 3.5
Table 1: AF vector Fermentation yields
Fig. 3: AF vector expression














































































Fig. 5: Vectors < 3kb have reduced copy number
Small vector replication
KanR and AF vectors < 3kb  have 
reduced copy number after plasmid 
induction in the fermentation process  
(Fig. 5, Table 3). Monomer and dimer 
fermentations demonstrated:
1) replication defect is due to reduced 
plasmid copy number induction; 
2) Reduced plasmid induction correlates 
with monomer subunit size < 3kb; and 
3)  Inducible fermentation process 
produces high quality monomer and 





























































Table 3: Vectors < 3kb have reduced copy number
Fig. 6: AF Monomer 
and dimer production
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